Zai Lab (ZLAB) EBIT Margin Growth (1y) (2020 - 2026)

Zai Lab (ZLAB) EBIT Margin Growth (1y) (2020 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin Growth (1y) (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn -143.00
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 78.00
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn 1,049.00
4 Revolution Medicines 43.64 Bn 43.64 Bn - -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 1,238.00
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn -10,520.00
7 Royalty Pharma 33.72 Bn 35.84 Bn - -1,651.00
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 2,002.00
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn 29,091.00
10 Zai Lab 2.91 Bn 2.20 Bn 58.15 Mn -2,203.00

Historic Data

Download Data
DateValue
Jun 30, 2026 -2,203.00
Mar 31, 2026 -1,678.00
Dec 31, 2025 785.00
Sep 30, 2025 2,430.00
Jun 30, 2025 2,577.00
Mar 31, 2025 2,780.00
Dec 31, 2024 12,609.00
Sep 30, 2024 5,437.00
Jun 30, 2024 5,429.00
Mar 31, 2024 3,003.00
Dec 31, 2023 -3,292.00
Sep 30, 2023 10,275.00
Jun 30, 2023 7,494.00
Mar 31, 2023 6,000.00
Dec 31, 2022 34,316.00
Sep 30, 2022 -3,043.00
Jun 30, 2022 25,691.00
Mar 31, 2022 95,893.00
Dec 31, 2021 13,250.00
Sep 30, 2021 32,745.00